2 Explosive Growth Stocks to Buy in April
The market has tested the patience of even the most seasoned of investors over the last year, and you're not alone if you've seen your portfolio struggle against the ongoing volatility. With even the most tried-and-true companies across a wide selection of industries seeing share prices buckle in this environment, it's more important than ever to consider where you put your investing capital to work and ensure that the underlying businesses align with your portfolio goals and risk tolerance.
If you're on the hunt for two compelling businesses to add to your buy basket this month, here are two names to consider right now.
DexCom (NASDAQ: DXCM) continues to derive substantial revenue growth and profits from its market-leading portfolio of continuous glucose monitoring (CGM) devices. The company's latest launch of its newest generation of its flagship CGM device, the G7, is underway in the U.S. and was already launched in other key international markets before the end of 2022 in Europe, Asia, and beyond.
Source Fool.com
